Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 700 of 2051 entries
View as:

Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)

Phase: N/A Priority: Normal
NCT ID: NCT02092285 Org: User:
Start: 05/09/14 End: 05/25/16 Due: 05/25/17

A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)

Phase: N/A Priority: Normal
NCT ID: NCT06643377 Org: User:
Start: 11/22/24 End: 06/26/25 Due: 06/26/26

Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00673465 Org: User:
Start: 04/17/08 End: 12/11/08 Due: 12/11/09

A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344)

Phase: N/A Priority: Normal
NCT ID: NCT02364752 Org: User:
Start: 09/30/15 End: 11/30/16 Due: 11/30/17

The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)

Phase: N/A Priority: Normal
NCT ID: NCT00441584 Org: User:
Start: 07/31/05 End: 06/30/08 Due: 06/30/09

Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)

Phase: N/A Priority: Normal
NCT ID: NCT00957957 Org: User:
Start: 02/28/10 End: 11/30/14 Due: 11/30/15

A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

Phase: N/A Priority: Normal
NCT ID: NCT05067283 Org: User:
Start: 12/17/21 End: 02/25/30 Due: 02/25/31

A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

Phase: N/A Priority: Normal
NCT ID: NCT05594043 Org: User:
Start: 12/21/22 End: 05/21/25 Due: 05/21/26

A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

Phase: N/A Priority: Normal
NCT ID: NCT04489888 Org: User:
Start: 10/27/20 End: 06/28/24 Due: 06/28/25

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Phase: N/A Priority: Normal
NCT ID: NCT06731907 Org: User:
Start: 03/30/25 End: 03/12/32 Due: 03/12/33

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

Phase: N/A Priority: Normal
NCT ID: NCT06788912 Org: User:
Start: 03/20/25 End: 02/07/32 Due: 02/07/33

Assessment of Long-Term Infliximab for Psoriasis (P05319)

Phase: N/A Priority: Normal
NCT ID: NCT00779675 Org: User:
Start: 10/31/08 End: 08/31/12 Due: 08/31/13

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

Phase: N/A Priority: Normal
NCT ID: NCT00543361 Org: User:
Start: 05/31/03 End: 12/31/03 Due: 12/31/04

Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)

Phase: N/A Priority: Normal
NCT ID: NCT02318693 Org: User:
Start: 02/04/15 End: 12/15/15 Due: 12/15/16

MK0686 in Postsurgery Dental Pain (0686-002)

Phase: N/A Priority: Normal
NCT ID: NCT00533403 Org: User:
Start: 07/31/04 End: 11/30/04 Due: 11/30/05

Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)

Phase: N/A Priority: Normal
NCT ID: NCT02750306 Org: User:
Start: 05/23/16 End: 09/30/18 Due: 09/30/19

A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00820664 Org: User:
Start: 12/31/08 End: 05/31/09 Due: 05/31/10

The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01130168 Org: User:
Start: 05/31/10 End: 11/30/10 Due: 11/30/11

An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

Phase: N/A Priority: Normal
NCT ID: NCT00109148 Org: User:
Start: 07/31/04 End: 02/28/05 Due: 02/28/06

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)

Phase: N/A Priority: Normal
NCT ID: NCT03480802 Org: User:
Start: 07/06/18 End: 01/17/20 Due: 01/17/21

Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)

Phase: N/A Priority: Normal
NCT ID: NCT01337674 Org: User:
Start: 04/01/11 End: 11/01/11 Due: 11/01/12

Effect of MK0524A on Flushing Caused by Niacin (0524A-056)

Phase: N/A Priority: Normal
NCT ID: NCT00533611 Org: User:
Start: 04/30/07 End: 08/31/07 Due: 08/31/08

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092482 Org: User:
Start: 06/28/02 End: 08/15/08 Due: 08/15/09

A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)

Phase: N/A Priority: Normal
NCT ID: NCT00546286 Org: User:
Start: 05/31/06 End: 08/23/07 Due: 08/23/08

A Study of MK-8189 in Participants With Schizophrenia (MK-8189-014)

Phase: N/A Priority: Normal
NCT ID: NCT05406440 Org: User:
Start: 07/12/22 End: 02/24/23 Due: 02/24/24